Covered recipient · General Payments record
GREGORY J OSHANICK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Brain Injury Medicine
General Payments · PY2018–2024
$7,624.68
- Reported across 235 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $701.66 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $303.40 | 31 |
| Lundbeck LLC | $136.45 | 9 |
| PFIZER INC. | $101.53 | 5 |
| Axsome Therapeutics, Inc. | $53.04 | 3 |
| Otsuka America Pharmaceutical, Inc. | $45.94 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.73 | 2 |
| Teva Pharmaceuticals USA, Inc. | $25.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.24 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142170 | CMS |
| ABBVIE INC. | $11.03 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142172 | CMS |
| ABBVIE INC. | $28.37 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142174 | CMS |
| ABBVIE INC. | $7.21 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142176 | CMS |
| ABBVIE INC. | $5.60 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142178 | CMS |
| ABBVIE INC. | $19.57 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142180 | CMS |
| ABBVIE INC. | $14.32 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142182 | CMS |
| ABBVIE INC. | $10.95 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142184 | CMS |
| ABBVIE INC. | $3.42 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142186 | CMS |
| ABBVIE INC. | $0.75 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142188 | CMS |
| ABBVIE INC. | $11.09 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142190 | CMS |
| ABBVIE INC. | $5.63 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142192 | CMS |
| ABBVIE INC. | $3.52 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142194 | CMS |
| ABBVIE INC. | $7.31 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142196 | CMS |
| ABBVIE INC. | $9.69 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142198 | CMS |
| ABBVIE INC. | $7.10 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142200 | CMS |
| ABBVIE INC. | $11.95 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142202 | CMS |
| ABBVIE INC. | $15.43 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142204 | CMS |
| ABBVIE INC. | $8.08 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142206 | CMS |
| ABBVIE INC. | $8.75 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142208 | CMS |
| ABBVIE INC. | $17.44 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142210 | CMS |
| ABBVIE INC. | $5.55 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142212 | CMS |
| ABBVIE INC. | $5.32 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142214 | CMS |
| ABBVIE INC. | $11.83 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142216 | CMS |
| ABBVIE INC. | $8.39 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142218 | CMS |
| ABBVIE INC. | $2.65 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142220 | CMS |
| ABBVIE INC. | $11.13 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142222 | CMS |
| ABBVIE INC. | $7.83 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142224 | CMS |
| ABBVIE INC. | $9.33 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142226 | CMS |
| ABBVIE INC. | $15.01 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142228 | CMS |
| ABBVIE INC. | $7.91 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142230 | CMS |
| Axsome Therapeutics, Inc. | $15.03 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148283309 | CMS |
| Axsome Therapeutics, Inc. | $22.78 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148283311 | CMS |
| Axsome Therapeutics, Inc. | $15.23 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148283313 | CMS |
| Lundbeck LLC | $5.73 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951883 | CMS |
| Lundbeck LLC | $22.53 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951885 | CMS |
| Lundbeck LLC | $24.02 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951887 | CMS |
| Lundbeck LLC | $12.14 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951889 | CMS |
| Lundbeck LLC | $21.78 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951891 | CMS |
| Lundbeck LLC | $8.73 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951893 | CMS |
| Lundbeck LLC | $16.23 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951895 | CMS |
| Lundbeck LLC | $20.29 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951897 | CMS |
| Lundbeck LLC | $5.00 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145951899 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.93 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118953256 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.01 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118953258 | CMS |
| PFIZER INC. | $18.02 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572257 | CMS |
| PFIZER INC. | $22.26 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131557288 | CMS |
| PFIZER INC. | $16.85 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131591554 | CMS |
| PFIZER INC. | $23.54 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131838786 | CMS |
| PFIZER INC. | $20.86 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131203419 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.40 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137645286 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.33 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137645288 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.57 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151568293 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.